Cargando…
MET Mutation Is a Potential Therapeutic Target for Advanced Endometrial Cancer
SIMPLE SUMMARY: Endometrial cancer is the most common gynecological cancer in developed countries. At initial diagnosis, extra-uterine spread is observed in about 25% of patients. Chemotherapy is the suggested mode of treatment for patients with extra-uterine metastasis; however, the 5-year overall...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392057/ https://www.ncbi.nlm.nih.gov/pubmed/34439385 http://dx.doi.org/10.3390/cancers13164231 |